Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intellia Therapeutics (NTLA) Other financing activities (2016)

Historic Other financing activities for Intellia Therapeutics (NTLA) over the last 2 years, with Q3 2016 value amounting to $1.7 million.

  • Intellia Therapeutics' Other financing activities changed N/A to $1.7 million in Q3 2016 from the same period last year, while for Dec 2016 it was $2.8 million, marking a year-over-year change of. This contributed to the annual value of $424000.0 for FY2018, which is N/A changed from last year.
  • As of Q3 2016, Intellia Therapeutics' Other financing activities stood at $1.7 million.
  • Over the past 5 years, Intellia Therapeutics' Other financing activities peaked at $1.7 million during Q3 2016, and registered a low of $207000.0 during Q4 2015.